Chi‐Wei Tao
Impact in
- Endocrinology top 5%
- Legionella and Acanthamoeba research
- Vibrio bacteria research studies
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 8
- Pulmonary Hypertension Research and Treatments 3
-
- Bacterial biofilms and quorum sensing 6
- Cancer therapeutics and mechanisms 3
- Co-authors
- Bing‐Mu Hsu (13 shared papers)Po-Min Kao (8 shared papers)Tsui-Kang Hsu (6 shared papers)Wen‐Tsai Ji (3 shared papers)Shu‐Min Shen (3 shared papers)Yuli Huang (2 shared papers)Jung‐Sheng Chen (6 shared papers)Hsu‐Shan Huang (7 shared papers)
In The Last Decade
Chi‐Wei Tao
35 papers receiving 485 citations
Peers
Comparison fields: 5 of 91
- Endocrinology 81
- Molecular Medicine 67
- Toxicology 28
- Pollution 83
- Pulmonary and Respiratory Medicine 125
Countries citing papers authored by Chi‐Wei Tao
This map shows the geographic impact of Chi‐Wei Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Wei Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Wei Tao more than expected).
Fields of papers citing papers by Chi‐Wei Tao
This network shows the impact of papers produced by Chi‐Wei Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Wei Tao. The network helps show where Chi‐Wei Tao may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Wei Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 92 | |
| 2 | 2013 | 36 | |
| 3 | 2006 | 24 | |
| 4 | 2020 | 23 | |
| 5 | 1992 | 20 | |
| 6 | 2013 | 19 | |
| 7 | 2018 | 19 | |
| 8 | 2015 | 19 | |
| 9 | 2006 | 19 | |
| 10 | 2002 | 16 | |
| 11 | 2002 | 15 | |
| 12 | 2015 | 15 | |
| 13 | 2014 | 15 | |
| 14 | 2017 | 12 | |
| 15 | 2015 | 12 | |
| 16 | 2015 | 12 | |
| 17 | 2006 | 11 | |
| 18 | 2015 | 11 | |
| 19 | 2021 | 10 | |
| 20 | 2001 | 10 |
About Chi‐Wei Tao
Chi‐Wei Tao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Endocrinology, Infectious Diseases and Toxicology, having authored 38 papers that have together received 491 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Bacterial biofilms and quorum sensing (6 papers), Legionella and Acanthamoeba research (5 papers), Bioactive Compounds and Antitumor Agents (5 papers), Synthesis and biological activity (4 papers), Viral gastroenteritis research and epidemiology (3 papers), Pulmonary Hypertension Research and Treatments (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Endocrinology (81 citations), Molecular Medicine (67 citations), Toxicology (28 citations), Pollution (83 citations) and Pulmonary and Respiratory Medicine (125 citations). Chi‐Wei Tao has collaborated with scholars based in Taiwan, Japan and China. Frequent co-authors include Bing‐Mu Hsu, Po-Min Kao, Tsui-Kang Hsu, Wen‐Tsai Ji, Shu‐Min Shen, Yuli Huang, Jung‐Sheng Chen, Hsu‐Shan Huang, Terng‐Jou Wan and Hui‐Fen Chiu. Their work appears in journals such as International Journal of COPD, Chemical and Pharmaceutical Bulletin, Environmental Science and Pollution Research, Ecotoxicology and Environmental Safety and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.